机构地区:[1]Jiangsu Province Key Laboratory. of Anaesthesiology, Xuzhou Medical College, Xuzhou 221002, China [2]Department of Anesthesiology, The Eighth People's Hospital of Guangzhou, Guangzhou 510060, China [3]Department of Anaesthesiology, Affiliated Foshan Hospital of Sun Yat- sen University, Foshan 528000, China [4]Department of Urologic Surgery, The Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002. China
出 处:《Acta Pharmacologica Sinica》2008年第8期931-941,共11页中国药理学报(英文版)
摘 要:Aim: The activation of extracellular signal-regulated kinase (ERK)1/2 protects against ischemic-reperfusion injury. Whether ERK1/2 mediates the cardioprotection of sevoflurane postconditioning is unknown. We tested whether sevoflurane postconditioning produces cardioprotection via an ERK1/2-dependent mechanism. Methods: In protocol 1, Langendorff-perfused Sprague-Dawley rat hearts (n=84, 12 per group), with the exception of the Sham group, were subjected to 30 rain ischemia followed by 90 rain reperfusion and were assigned to the untreated (control) group, followed by 4 cycles of ischemic postconditioning (25 s of each), 3% (v/v) sevoflurane postconditioning (for 5 min and 10 min of washout), and the PD98059 solvent DMSO (〈0.2%), ERK1/2 inhibitor PD98059 (20 μmol/L), and Sevo±PD administration. Left ventricular hemodynamics and coronary flow at 30 min of equilibrium were recorded at 30, 60, and 90 min of reperfusion, respectively. Acute infarct size was measured by triphenyltetrazolium chloride staining. The configuration of mitochondria was observed by an electron microscope. Western blot analysis was used to determine the contents of cytosolic and mitochondrial cytochrome c at the end of reperfusion. In protocol 2, after 15 min of reperfusion, the expression of total and phosphorylated forms of ERK1/2 and its downstream target p70S6K was determined by Western blotting. Results: No differences in baseline hemodynamics were observed among the experimental groups (P〉0.05). After reperfusion, compared with the control group, sevoflurane postconditioning and ischemic postconditioning significantly (P〈0.05) improved functional recovery and largely (P〈0.05) decreased myocardial infarct size (22.9%±4.6% and 21.2%±3.8%, vs 39.4%± 5.7%, both P〈0.05). Sevoflurane-mediated protection was abolished by PD98059. Conclusion: Anesthetic postconditioning by sevoflurane effectively protects against reperfusion damage by activating ERK1/2 in vitro.Aim: The activation of extracellular signal-regulated kinase (ERK)1/2 protects against ischemic-reperfusion injury. Whether ERK1/2 mediates the cardioprotection of sevoflurane postconditioning is unknown. We tested whether sevoflurane postconditioning produces cardioprotection via an ERK1/2-dependent mechanism. Methods: In protocol 1, Langendorff-perfused Sprague-Dawley rat hearts (n=84, 12 per group), with the exception of the Sham group, were subjected to 30 rain ischemia followed by 90 rain reperfusion and were assigned to the untreated (control) group, followed by 4 cycles of ischemic postconditioning (25 s of each), 3% (v/v) sevoflurane postconditioning (for 5 min and 10 min of washout), and the PD98059 solvent DMSO (〈0.2%), ERK1/2 inhibitor PD98059 (20 μmol/L), and Sevo±PD administration. Left ventricular hemodynamics and coronary flow at 30 min of equilibrium were recorded at 30, 60, and 90 min of reperfusion, respectively. Acute infarct size was measured by triphenyltetrazolium chloride staining. The configuration of mitochondria was observed by an electron microscope. Western blot analysis was used to determine the contents of cytosolic and mitochondrial cytochrome c at the end of reperfusion. In protocol 2, after 15 min of reperfusion, the expression of total and phosphorylated forms of ERK1/2 and its downstream target p70S6K was determined by Western blotting. Results: No differences in baseline hemodynamics were observed among the experimental groups (P〉0.05). After reperfusion, compared with the control group, sevoflurane postconditioning and ischemic postconditioning significantly (P〈0.05) improved functional recovery and largely (P〈0.05) decreased myocardial infarct size (22.9%±4.6% and 21.2%±3.8%, vs 39.4%± 5.7%, both P〈0.05). Sevoflurane-mediated protection was abolished by PD98059. Conclusion: Anesthetic postconditioning by sevoflurane effectively protects against reperfusion damage by activating ERK1/2 in vitro.
关 键 词:SEVOFLURANE POSTCONDITIONING extracellular signal-regulated protein kinase p70S6kinase MITOCHONDRIA cytochrome c ISCHEMIA-REPERFUSION
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...